These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33372800)

  • 41. Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A
    Varano F; Catarzi D; Falsini M; Vincenzi F; Pasquini S; Varani K; Colotta V
    Bioorg Med Chem; 2018 Jul; 26(12):3688-3695. PubMed ID: 29880250
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists.
    Vazquez-Rodriguez S; Matos MJ; Santana L; Uriarte E; Borges F; Kachler S; Klotz KN
    J Pharm Pharmacol; 2013 May; 65(5):697-703. PubMed ID: 23600387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: structural investigations at the 5-position to target human A₁ and A(2A) adenosine receptors. Molecular modeling and pharmacological studies.
    Squarcialupi L; Colotta V; Catarzi D; Varano F; Betti M; Varani K; Vincenzi F; Borea PA; Porta N; Ciancetta A; Moro S
    Eur J Med Chem; 2014 Sep; 84():614-27. PubMed ID: 25063944
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The significance of 2-furyl ring substitution with a 2-(para-substituted) aryl group in a new series of pyrazolo-triazolo-pyrimidines as potent and highly selective hA(3) adenosine receptors antagonists: new insights into structure-affinity relationship and receptor-antagonist recognition.
    Cheong SL; Dolzhenko A; Kachler S; Paoletta S; Federico S; Cacciari B; Dolzhenko A; Klotz KN; Moro S; Spalluto G; Pastorin G
    J Med Chem; 2010 Apr; 53(8):3361-75. PubMed ID: 20307065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel non-xanthine antagonist of the A
    Härter M; Kalthof B; Delbeck M; Lustig K; Gerisch M; Schulz S; Kast R; Meibom D; Lindner N
    Eur J Med Chem; 2019 Feb; 163():763-778. PubMed ID: 30576906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allosteric modulators of human A2B adenosine receptor.
    Trincavelli ML; Giacomelli C; Daniele S; Taliani S; Cosimelli B; Laneri S; Severi E; Barresi E; Pugliesi I; Greco G; Novellino E; Da Settimo F; Martini C
    Biochim Biophys Acta; 2014 Mar; 1840(3):1194-203. PubMed ID: 24361612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl Moiety on the Adenosine Receptors Affinity Profile of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidine Derivatives.
    Federico S; Redenti S; Sturlese M; Ciancetta A; Kachler S; Klotz KN; Cacciari B; Moro S; Spalluto G
    PLoS One; 2015; 10(12):e0143504. PubMed ID: 26625265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 8-(Furan-2-yl)-3-phenethylthiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine-2(3H)-thione as novel, selective and potent adenosine A(2A) receptor antagonist.
    Kumari N; Mishra CB; Prakash A; Kumar N; Mongre R; Luthra PM
    Neurosci Lett; 2014 Jan; 558():203-7. PubMed ID: 24161891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor Antagonists.
    Crespo A; El Maatougui A; Biagini P; Azuaje J; Coelho A; Brea J; Loza MI; Cadavid MI; García-Mera X; Gutiérrez-de-Terán H; Sotelo E
    ACS Med Chem Lett; 2013 Nov; 4(11):1031-6. PubMed ID: 24900602
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity.
    Varano F; Catarzi D; Falsini M; Dal Ben D; Buccioni M; Marucci G; Volpini R; Colotta V
    Bioorg Med Chem Lett; 2019 Feb; 29(4):563-569. PubMed ID: 30638876
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation.
    Squarcialupi L; Colotta V; Catarzi D; Varano F; Filacchioni G; Varani K; Corciulo C; Vincenzi F; Borea PA; Ghelardini C; Di Cesare Mannelli L; Ciancetta A; Moro S
    J Med Chem; 2013 Mar; 56(6):2256-69. PubMed ID: 23427825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships.
    Stefanachi A; Nicolotti O; Leonetti F; Cellamare S; Campagna F; Loza MI; Brea JM; Mazza F; Gavuzzo E; Carotti A
    Bioorg Med Chem; 2008 Nov; 16(22):9780-9. PubMed ID: 18938084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of A2B adenosine receptor functioning by tumour necrosis factor a in human astroglial cells.
    Trincavelli ML; Marroni M; Tuscano D; Ceruti S; Mazzola A; Mitro N; Abbracchio MP; Martini C
    J Neurochem; 2004 Dec; 91(5):1180-90. PubMed ID: 15569261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel N2-substituted pyrazolo[3,4-d]pyrimidine adenosine A3 receptor antagonists: inhibition of A3-mediated human glioblastoma cell proliferation.
    Taliani S; La Motta C; Mugnaini L; Simorini F; Salerno S; Marini AM; Da Settimo F; Cosconati S; Cosimelli B; Greco G; Limongelli V; Marinelli L; Novellino E; Ciampi O; Daniele S; Trincavelli ML; Martini C
    J Med Chem; 2010 May; 53(10):3954-63. PubMed ID: 20408530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allosteric Antagonism of the A
    Gao ZG; Toti KS; Campbell R; Suresh RR; Yang H; Jacobson KA
    Cells; 2020 May; 9(5):. PubMed ID: 32408534
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Toward PET imaging of A2B adenosine receptors: a carbon-11 labeled triazinobenzimidazole tracer: Synthesis and imaging of a new A2B PET tracer.
    Petroni D; Giacomelli C; Taliani S; Barresi E; Robello M; Daniele S; Bartoli A; Burchielli S; Pardini S; Salvadori PA; Da Settimo F; Martini C; Trincavelli ML; Menichetti L
    Nucl Med Biol; 2016 May; 43(5):309-17. PubMed ID: 27150034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A(3) adenosine receptor antagonists.
    Baraldi PG; Cacciari B; Moro S; Spalluto G; Pastorin G; Da Ros T; Klotz KN; Varani K; Gessi S; Borea PA
    J Med Chem; 2002 Feb; 45(4):770-80. PubMed ID: 11831890
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subtype-Selective Fluorescent Ligands as Pharmacological Research Tools for the Human Adenosine A
    Comeo E; Kindon ND; Soave M; Stoddart LA; Kilpatrick LE; Scammells PJ; Hill SJ; Kellam B
    J Med Chem; 2020 Mar; 63(5):2656-2672. PubMed ID: 31887252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Capadenoson, a clinically trialed partial adenosine A
    Baltos JA; Vecchio EA; Harris MA; Qin CX; Ritchie RH; Christopoulos A; White PJ; May LT
    Biochem Pharmacol; 2017 Jul; 135():79-89. PubMed ID: 28344125
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A2A and A2B receptors ligands.
    Lambertucci C; Antonini I; Buccioni M; Dal Ben D; Kachare DD; Volpini R; Klotz KN; Cristalli G
    Bioorg Med Chem; 2009 Apr; 17(7):2812-22. PubMed ID: 19282184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.